| Literature DB >> 31655855 |
Fernanda O Carvalho1, Érika R Silva1, Paula S Nunes2, Fernanda A Felipe1, Karen P P Ramos1, Luiz Augusto S Ferreira1, Viviane N B Lima1, Saravanan Shanmugam3, Alan Santos Oliveira1, Sílvia S Guterres4, Enilton A Camargo1, Tassia Virginia Cravalho Olivera5, Ricardo Luiz C de Albuquerque Júnior5, Waldecy de Lucca Junior1, Lucindo José Quintans-Júnior1, Adriano A S Araújo1.
Abstract
The aim of this present study was to evaluate the effect of solid lipid nanoparticles (SLN) containing carvacrol over the lung damage of airway smoke inhalation. The study was conducted with 30 rats subjected to smoke inhalation and divided into 5 groups such as, normal control, negative control, oxygen group, SLN alone, and SLN+CARV group. The animals were sacrificed 24 h after the induction of inhalation injury further, the tissues of larynx, trachea, and lungs were collected for the histological, hematological, myeloperoxidase, and malondialdehyde analysis. The obtained results showed that treatment with CARV+SLN minimized the inhalation injury, since it reduced malondialdehyde significantly, when compared to the negative control group and minimized the histological changes which proves the absence of pulmonary emphysema and exudate in laryngeal and tracheal lumen in the CARV+SLN-treated group. Meanwhile, the presence of lesion with chronic characteristics was observed in the negative control and oxygen groups. It is suggested that the SLN containing carvacrol minimized oxidative stress and histological damages generated from smoke inhalation in rodents.Entities:
Keywords: Carvacrol; Inhalation; Lung injury; Natural product; Smoke; Solid lipid nanoparticle
Year: 2019 PMID: 31655855 DOI: 10.1007/s00210-019-01731-1
Source DB: PubMed Journal: Naunyn Schmiedebergs Arch Pharmacol ISSN: 0028-1298 Impact factor: 3.000